- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Rated
5.0
out of 5 stars
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 422 publications
- Percutaneous Coronary Intervention , 215 publications
- Clopidogrel , 189 publications
- Acute Coronary Syndrome , 160 publications
Research activity
Active clinical trials
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 45 Years - 99 Years
- Sexes
- All
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
My publications
Filter publications
868 publications
2026
Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 survey.
International journal of cardiology
PubMed • Publisher's site2026
Safety and optimal use of direct oral anticoagulant therapy.
Expert opinion on drug safety
PubMed • Publisher's site2026
2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping
Journal of the American Heart Association
Publisher's site2026
Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial
Journal of Clinical Medicine
Publisher's site2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention
Clinical Pharmacology & Therapeutics
Publisher's site